Attached files
| file | filename |
|---|---|
| EX-21 - EXHIBIT 21 - ENCORIUM GROUP INC | ex21.htm |
| EX-32.2 - EXHIBIT 32.2 - ENCORIUM GROUP INC | ex32_2.htm |
| EX-23.1 - EXHIBIT 23.1 - ENCORIUM GROUP INC | ex23_1.htm |
| EX-31.1 - EXHIBIT 31.1 - ENCORIUM GROUP INC | ex31_1.htm |
| EX-31.2 - EXHIBIT 31.2 - ENCORIUM GROUP INC | ex31_2.htm |
| 10-K - FOR THE FISCAL YEAR ENDED DECEMBER 31, 2010 - ENCORIUM GROUP INC | j91511110k.htm |
Exhibit 32.1
ENCORIUM GROUP, INC.
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Encorium Group, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Dr. Kai Lindevall, M. D. Ph.D. Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
|
(1)
|
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
(2)
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
|
/S/ Dr. Kai Lindevall, M.D., Ph.D
|
|
Dr. Kai Lindevall, M.D., Ph.D.
|
|
Chief Executive Officer
(Principal Executive Officer) and Director
|
October 3, 2011
The foregoing certification is being furnished solely pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (Section 1350 of Chapter 63 of Title 18 of the United States Code) and is not being filed as part of the Report or as a separate disclosure document.